Impax Laboratories, Inc., et al. v. Lannett Holding Inc., et al., C.A. No. 14-984 - RGA, December 1, 2015.
Andrews, J. Claim construction opinion issues regarding three terms from two patents. A Markman hearing took place on November 16, 2015
The disputed technology relates to pharmaceutical formulations. The following terms were considered:
-
“preambles”
-
“zolmitriptan”
-
“buffer”, “buffered”, “in a buffer”